I Miranda1, E Sánchez-Alepuz2, F J Lucas3, V Carratalá3, C A González-Jofre4. 1. Servicio de Cirugía Ortopédica y Traumatología de Unión de Mutuas, Valencia, España; Servicio de Cirugía Ortopédica y Traumatología, Hospital IMED Valencia, Burjassot, Valencia, España. Electronic address: nachomigo@hotmail.com. 2. Servicio de Cirugía Ortopédica y Traumatología de Unión de Mutuas, Valencia, España; Servicio de Cirugía Ortopédica y Traumatología, Hospital IMED Valencia, Burjassot, Valencia, España. 3. Servicio de Cirugía Ortopédica y Traumatología de Unión de Mutuas, Valencia, España. 4. Servicio de Cirugía Ortopédica y Traumatología, Hospital Carlos Van Buren, Valparaiso, Chile; Servicio de Cirugía Ortopédica y Traumatología, Mutual de Seguridad de la Cámara Chilena de la Construcción, Valparaiso, Chile.
Abstract
PURPOSE: To analyze the current scientific and/or clinical evidence supporting the use of platelet-rich plasma (PRP) in the treatment of rotator cuff pathology. METHODS: After a systematic review in PubMed, studies assessing PRP efficacy in the treatment of rotator cuff pathology published since 2013 to date were identified. Data were grouped based on type of study (laboratory, clinical or meta-analysis); accordingly study design, pathology treated and clinical outcomes were summarized. RESULTS: Thirty five articles have been analyzed: 10 laboratory studies, 17 clinical assays and 8 meta-analyses. While laboratory studies report positive or partially positive results for the use of PRP, 70.6% of clinical studies and 75% of meta-analysis found no statistically significant differences between the PRP group and the control group. DISCUSSION: The positive results of laboratory studies do not translate well to clinical practice. There is no concordance among the few positive results reported in the clinical studies, and even some contradictory effects have been reported. CONCLUSIONS: There is no solid scientific and/or clinical evidence supporting the use of PRP in the treatment of rotator cuff pathology in routine clinical practice.
PURPOSE: To analyze the current scientific and/or clinical evidence supporting the use of platelet-rich plasma (PRP) in the treatment of rotator cuff pathology. METHODS: After a systematic review in PubMed, studies assessing PRP efficacy in the treatment of rotator cuff pathology published since 2013 to date were identified. Data were grouped based on type of study (laboratory, clinical or meta-analysis); accordingly study design, pathology treated and clinical outcomes were summarized. RESULTS: Thirty five articles have been analyzed: 10 laboratory studies, 17 clinical assays and 8 meta-analyses. While laboratory studies report positive or partially positive results for the use of PRP, 70.6% of clinical studies and 75% of meta-analysis found no statistically significant differences between the PRP group and the control group. DISCUSSION: The positive results of laboratory studies do not translate well to clinical practice. There is no concordance among the few positive results reported in the clinical studies, and even some contradictory effects have been reported. CONCLUSIONS: There is no solid scientific and/or clinical evidence supporting the use of PRP in the treatment of rotator cuff pathology in routine clinical practice.
Authors: Jason L Hurd; Tiffany R Facile; Jennifer Weiss; Matthew Hayes; Meredith Hayes; John P Furia; Nicola Maffulli; Glenn E Winnier; Christopher Alt; Christoph Schmitz; Eckhard U Alt; Mark Lundeen Journal: J Orthop Surg Res Date: 2020-03-30 Impact factor: 2.359